Medios AG raises forecasts for 2019 financial year

Medios AG / Key word(s): Change in Forecast
Medios AG raises forecasts for 2019 financial year

23-Sep-2019 / 10:47 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Medios AG raises forecasts for 2019 financial year

Berlin, 23 September 2019 - Medios AG ('Medios') raises its forecasts for the 2019 financial year. The Management Board is now expecting group sales of EUR 500 to 510 million (previous year EUR 328 million), group earnings before interest, taxes, depreciation and amortization (EBITDA), adjusted for extraordinary expenses*, of EUR 17 to 18 million (previous year EUR 11.7 million) as well as group earnings before taxes (EBT), adjusted for extraordinary expenses*, of EUR 15 to 16 million (previous year EUR 11.0 million). Previously, the Management Board had expected that it would at least reach the upper end of the forecasted sales target range of EUR 430 to 440 million. It had also forecasted adjusted EBITDA* of EUR 16.5 to 17.5 million and adjusted EBT* of EUR 14.5 to 15.5 million.

The reasons for the raised forecasts are increasingly positive impulses from the increased investments in the growth of the Medios Group. Since the beginning of the second half of 2019, these have had an even greater impact on the sales and earnings development of Medios than the Management Board had expected.

As far as currently foreseeable, the forecasts take into account legal changes and additional growth investments.

Matthias Gärtner, CFO of Medios AG

Medios AG, Friedrichstraße 113a, 10117 Berlin, Germany
Phone: +49 30 232 5668 0; Fax: +49 30 232 5668 01


* EBITDA and EBT are each adjusted proportionately for extraordinary expenses for stock options in the amount of EUR 1.28 million (non-cash) for the 2019 financial year. EBT are also adjusted proportionately for extraordinary expenses for amortization of EUR 0.60 million (non-cash) on the customer base as a result of the acquisition of parts of BerlinApotheke Schneider & Oleski oHG in the 2019 financial year.

Information and Explanation of the Issuer to this News:

About Medios AG
Medios AG is one of the leading Specialty Pharma companies in Germany. As a specialist for the provision of Specialty Pharma drugs to patients and GMP-certified provider of patient-specific therapies, Medios covers substantial elements of the supply chain in this field and follows the highest international quality standards. Usually, Specialty Pharma drugs are high-priced medicines for rare and/or chronic diseases. Patient-specific therapies are, for example, infusions that are compiled and produced on the basis of individual diseases and parameters like body weight and surface. It is Medios' aim to provide integrated solutions along the value chain to partners and clients, thereby ensuring an optimal pharmaceutical care for patients.

Medios AG is Germany's first publicly listed Specialty Pharma company. The share (WKN: A1MMCC, ISIN: DE000A1MMCC8) is listed in the Regulated Market of the Frankfurt Stock Exchange (General Standard).

Kirchhoff Consult AG
Nikolaus Hammerschmidt
Borselstraße 20
22765 Hamburg
Tel.: +49 40 60918618
Fax: +49 40 60918660

This release is a mandatory announcement pursuant to Art. 17 of the Market Abuse Regulation (MAR). The assessments contained therein are, as always, subject to the disclaimer provided below.

Cautionary note regarding forward-looking statements/No duty to update
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.

This publication constitutes neither an offer to sell nor an invitation to buy securities. It may not be published, distributed or transmitted, directly or indirectly, in the United States of America (including its territories and possessions), Canada, Japan or Australia or any other jurisdiction where such an announcement could be unlawful. This announcement does not constitute a recommendation concerning the purchase or sale of securities described in this announcement.

23-Sep-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Company:Medios AG
Friedrichstraße 113a
10117 Berlin
Phone:+49 30 232 566 - 800
Fax:+49 30 232 566 - 801
Listed:Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Dusseldorf
EQS News ID:877885

End of AnnouncementDGAP News Service


show this